Ancistrocladus ileboensis
Ancistrocladus ileboensis · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Ancistrocladus ileboensis is a specialized botanical species that has garnered significant scientific interest due to its unique chemical properties. Researchers are currently investigating the bioactive compounds found within its root to determine their therapeutic potential. Preliminary studies suggest that extracts from this plant may offer medicinal pathways for addressing complex conditions such as Multiple Myeloma and pancreatic cancer. Furthermore, its pharmacological profile is being examined for its efficacy against the malaria parasite Plasmodium falciparum. This exploration highlights the vital role of diverse flora in the ongoing search for new oncological and antiparasitic treatments.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Ancistrocladaceae
- Distribution
- Not available
- Plant Parts
- Root
Classification
Taxonomy
Ancistrocladus ileboensis is a fascinating botanical specimen that belongs to the kingdom Plantae. This specific plant is classified under the class Equisetopsida, marking its place within a distinct evolutionary lineage. It is a member of the order Caryophyllales, which connects it to a diverse range of other flowering plants. Within this order, it is further categorized into the family Ancistrocladaceae. Finally, it is identified by its unique scientific genus, Ancistrocladus.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Caryophyllales |
| Family | Ancistrocladaceae |
| Genus | Ancistrocladus |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Ancistrocladus ileboensis is a specialized plant species primarily found within the dense ecosystems of Africa. Its geographic range is specifically concentrated in the West-Central Tropical Africa region. Within this vast area, the plant is most notably identified in the Congo. This localized distribution highlights the specific environmental requirements necessary for its survival. Understanding its presence in these tropical habitats is essential for studying the botanical diversity of the continent.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Ancistrocladus ileboensis is characterized by an obligatory climbing habit, meaning it relies entirely on other structures for physical support to reach sunlight.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Ancistrocladus ileboensis is a recently described Congolese liana that serves as a rich source of unique naphthylisoquinoline alkaloids. Researchers have successfully isolated several specialized compounds from this plant, including the dioncophylline F alkaloid. In addition to this finding, the plant was found to contain the dioncophylline D2 compound. These specific alkaloids are of significant interest due to their potential biological properties. Ultimately, the chemical diversity found within Ancistrocladus ileboensis offers promising avenues for medicinal research.
Conditions
Ancistrocladus ileboensis produces various naphthylisoquinoline alkaloids that demonstrate significant medicinal potential against several serious conditions. The plant's metabolites, such as jozilebomines, exhibit potent cytotoxicity against HeLa human cervical cancer cells and show preferential activity against the PANC-1 human pancreatic cancer cell line. Furthermore, specific compounds isolated from this liana demonstrate strong cytotoxic effects against both multiple myeloma and various leukemia cell lines, including multidrug-resistant strains. Beyond its anticancer properties, the plant also contains dioncophyllines that possess high and specific antiplasmodial activities against the malaria parasite Plasmodium falciparum. These diverse biological activities highlight the plant's importance as a source for future drug development.
Preparations
Parts used
Ancistrocladus ileboensis is a Congolese liana that serves as a significant source of bioactive secondary metabolites. Researchers have successfully isolated two new naphthylisoquinoline dimers, known as jozilebomines A and B, specifically from the roots of this plant. These unique compounds are characterized by their unprecedented 3',6″-coupling and a constitutionally unsymmetric structure. Beyond their structural novelty, these dimers have demonstrated potent cytotoxicity against human pancreatic cancer cell lines. Consequently, these root-derived metabolites represent promising candidates for future pharmaceutical development in oncology.